Hedge Funds Are Crazy About Synta Pharmaceuticals Corp. (SNTA)

Page 1 of 2

Is Synta Pharmaceuticals Corp. (NASDAQ:SNTA) the right pick for your portfolio? The smart money is buying. The number of long hedge fund bets improved by 2 lately.

In the eyes of most investors, hedge funds are assumed to be underperforming, old financial vehicles of years past. While there are over 8000 funds in operation at the moment, we at Insider Monkey hone in on the masters of this club, about 450 funds. It is widely believed that this group has its hands on the majority of all hedge funds’ total capital, and by tracking their top picks, we have brought to light a few investment strategies that have historically outperformed Mr. Market. Our small-cap hedge fund strategy outperformed the S&P 500 index by 18 percentage points per annum for a decade in our back tests, and since we’ve started sharing our picks with our subscribers at the end of August 2012, we have topped the S&P 500 index by 23.3 percentage points in 8 months (check out a sample of our picks).

Synta Pharmaceuticals Corp. (NASDAQ:SNTA)Just as key, positive insider trading activity is a second way to parse down the stock market universe. As the old adage goes: there are a number of reasons for an insider to sell shares of his or her company, but only one, very clear reason why they would buy. Many empirical studies have demonstrated the market-beating potential of this tactic if shareholders know what to do (learn more here).

Consequently, we’re going to take a glance at the key action encompassing Synta Pharmaceuticals Corp. (NASDAQ:SNTA).

How are hedge funds trading Synta Pharmaceuticals Corp. (NASDAQ:SNTA)?

At the end of the first quarter, a total of 14 of the hedge funds we track were bullish in this stock, a change of 17% from the first quarter. With hedgies’ capital changing hands, there exists a select group of key hedge fund managers who were boosting their stakes considerably.

Of the funds we track, Julian Baker and Felix Baker’s Baker Bros. Advisors had the largest position in Synta Pharmaceuticals Corp. (NASDAQ:SNTA), worth close to $12.6 million, comprising 0.3% of its total 13F portfolio. Coming in second is Daniel Gold of QVT Financial, with a $11.5 million position; 0.8% of its 13F portfolio is allocated to the stock. Remaining hedgies that hold long positions include Joseph Edelman’s Perceptive Advisors, Mark Broach’s Manatuck Hill Partners and Richard Driehaus’s Driehaus Capital.

As one would reasonably expect, key hedge funds have been driving this bullishness. Scoggin, managed by Curtis Schenker and Craig Effron, initiated the largest call position in Synta Pharmaceuticals Corp. (NASDAQ:SNTA). Scoggin had 3.3 million invested in the company at the end of the quarter. Steven Cohen’s SAC Capital Advisors also initiated a $2.2 million position during the quarter. The following funds were also among the new SNTA investors: Curtis Schenker and Craig Effron’s Scoggin, Jim Simons’s Renaissance Technologies, and Louis Bacon’s Moore Global Investments.

Insider trading activity in Synta Pharmaceuticals Corp. (NASDAQ:SNTA)

Bullish insider trading is best served when the company we’re looking at has seen transactions within the past six months. Over the last 180-day time frame, Synta Pharmaceuticals Corp. (NASDAQ:SNTA) has experienced zero unique insiders buying, and zero insider sales (see the details of insider trades here).

Let’s go over hedge fund and insider activity in other stocks similar to Synta Pharmaceuticals Corp. (NASDAQ:SNTA). These stocks are Trinity Biotech plc (ADR) (NASDAQ:TRIB), Meridian Bioscience, Inc. (NASDAQ:VIVO), SurModics, Inc. (NASDAQ:SRDX), Quidel Corporation (NASDAQ:QDEL), and AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG). All of these stocks are in the diagnostic substances industry and their market caps are closest to SNTA’s market cap.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!